GeoVax Labs, Inc. (GOVX)
0.206
-0.01
(-3.15%)
USD |
NASDAQ |
Oct 23, 16:00
0.2035
0.00 (0.00%)
After-Hours: 20:00
GeoVax Labs EPS Diluted (Quarterly) : -0.9696 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.9696 |
| March 31, 2026 | -2.620 |
| December 31, 2025 | -2.551 |
| September 30, 2025 | -7.787 |
| June 30, 2025 | -8.740 |
| March 31, 2025 | -0.4482 |
| December 31, 2024 | -19.60 |
| September 30, 2024 | -0.908 |
| June 30, 2024 | -1.994 |
| March 31, 2024 | -2.472 |
| December 31, 2023 | -3.866 |
| September 30, 2023 | -4.752 |
| June 30, 2023 | -3.362 |
| March 31, 2023 | -2.300 |
| December 31, 2022 | -3.067 |
| September 30, 2022 | -2.537 |
| June 30, 2022 | -2.643 |
| March 31, 2022 | -5.122 |
| December 31, 2021 | -32.30 |
| September 30, 2021 | -4.608 |
| June 30, 2021 | -3.117 |
| March 31, 2021 | -4.396 |
| December 31, 2020 | -5.229 |
| September 30, 2020 | -10.93 |
| June 30, 2020 | -9.879 |
| Date | Value |
|---|---|
| March 31, 2020 | -38.12 |
| December 31, 2019 | -588.00 |
| September 30, 2019 | -19530.00 |
| June 30, 2019 | -604308.0 |
| March 31, 2019 | -855000.0 |
| December 31, 2018 | -870000.0 |
| September 30, 2018 | -1.194M |
| June 30, 2018 | -1.230M |
| March 31, 2018 | -1.503M |
| December 31, 2017 | -1.452M |
| September 30, 2017 | -3.000M |
| June 30, 2017 | -3.000M |
| March 31, 2017 | -3.000M |
| December 31, 2016 | -6.000M |
| September 30, 2016 | -3.000M |
| June 30, 2016 | -6.000M |
| March 31, 2016 | -12.00M |
| December 31, 2015 | -6.000M |
| September 30, 2015 | -6.000M |
| June 30, 2015 | -6.000M |
| March 31, 2015 | -6.000M |
| December 31, 2014 | -9.000M |
| September 30, 2014 | -6.000M |
| June 30, 2014 | -9.000M |
| March 31, 2014 | -6.000M |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.427M |
| Total Expenses (Quarterly) | 4.427M |
| Enterprise Value | -1.302M |
| Earnings Yield | -6.76K% |
| Normalized Earnings Yield | -6760.97 |